SCHEMBL715196

SCHEMBL715196

CCCCCCC1CCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.47
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
GAA P10253 1/20 0.39
EPHX1 P07099 1/20 0.38
HLCS P50747 1/20 0.38
CYP19A1 P11511 3/20 0.38
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8024040 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL115579 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27762281 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
Nonane SCHEMBL17844420 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6897307 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL486901 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27960807 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL29114737 1.00 CYP1A2 (0.47) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL113288 0.98 CYP1A2 (0.44) CYP1A2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL13900594 0.98 CYP1A2 (0.44) CYP1A2NPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 785 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
CN-119156438-A Perfume composition for sleep improvement 国际香料和香精公司 2024-12-17 CN claimed
WO-2024213507-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-10-17 WO claimed
EP-4446001-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2024-10-16 EP claimed
CN-118772099-A Synthesis method of high-purity delta undecalactone 江苏宏邦化工科技有限公司 2024-10-15 CN claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
CN-113873884-B Arthropod control composition 弗门尼舍有限公司 2024-06-14 CN claimed
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2024-02-15 US claimed
CN-117019033-A Production device and method of 4-methyl-delta-decalactone perfume 安徽华业香料股份有限公司 2023-11-10 CN claimed
WO-2005105970-A1 LIQUID LAUNDRY DETERGENT COMPOSITIONS WITH SILICONE BLENDS AS FABRIC CARE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2005-11-10 WO claimed
WO-2005103214-A2 PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2005-11-03 WO claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
US-20050233938-A1 Liquid laundry detergent compositions with silicone blends as fabric care agents PROCTER & GAMBLE COMPANY, THE 2005-10-20 US claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
US-6780835-B2 DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX QUEST INTERNATIONAL B.V. (NL) 2004-08-24 US claimed
US-6126930-A REDUCING TRIGEMINAL STIMULATION FROM AN ATOMIZED ALCOHOL THE PROCTER & GAMBLE COMPANY (US) 2000-10-03 US claimed
CN-1251983-A Spray compositions PROCTER & GAMBLE (US) 2000-05-03 CN claimed
EP-0986367-A1 SPRAY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-03-22 EP claimed
WO-1998035651-A1 SPRAY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-08-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS OR10J3, OR51E2, MAL2 CYP1A2 90/4885NPC1 3331/4885RAB9A 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.